A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days.
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This is an exploratory study to examine the effect of iNOS inhibition in rheumatoid arthritis
patients. The study involves 28 days repeat dosing with GW274150 (dose determined by the
results from a previous study), prednisolone (7.5mg) or placebo.